Tom Frohlich
CIK: 0001823925
Transaction Breakdown
Open Market Buys (P)1 (50.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
JBIO
Jade Biosciences, Inc.
DirectorOfficer
Discretionary Trading P&L
Holdings
About Frohlich Tom
Frohlich Tom (SEC CIK 0001823925) files insider reports with the SEC as Chief Executive Officer of Jade Biosciences, Inc. (JBIO).
Signal8 holds 3 ownership filings by Frohlich Tom (1 Form 3, 2 Form 4), filed between May 1, 2025 and Feb 13, 2026. Those filings report 2 transactions, from May 16, 2025 to Feb 12, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Frohlich Tom's filings is in WALTHAM, MA.
Recent filings by Frohlich Tom
Other insiders filing for Jade Biosciences, Inc. (JBIO)
- Eisner Mark, Director
- CAIN CHRISTOPHER W., Director
- DOBMEIER ERIC, Director
- Klein Lawrence Otto, Director
- Lavelle Erin, Director
- Fairmount Funds Management LLC, Director